Indo US Bio-Tech Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is -26.09% vs 0.26% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -13.04% vs -26.60% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -0.48% vs -23.77% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is 83.33% vs -6.67% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Indo US Bio-Tech With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

22.80

260.14

-237.34

-91.24%

Other Operating Income

0.00

Total Operating income

22.80

260.14

-237.34

-91.24%

Raw Material Cost

0.00

184.87

-184.87

-100.00%

Purchase of Finished goods

20.34

2.44

17.90

733.61%

(Increase) / Decrease In Stocks

-19.96

3.83

-23.79

-621.15%

Employee Cost

0.33

16.76

-16.43

-98.03%

Power Cost

0.00

Manufacturing Expenses

15.60

-0.01

15.61

156,100.00%

Selling and Distribution Expenses

0.00

Other Expenses

2.34

38.32

-35.98

-93.89%

Total Expenditure (Excl Depreciation)

18.65

246.21

-227.56

-92.43%

Operating Profit (PBDIT) excl Other Income

4.15

13.93

-9.78

-70.21%

Other Income

0.01

1.78

-1.77

-99.44%

Operating Profit (PBDIT)

4.16

15.71

-11.55

-73.52%

Interest

0.77

6.23

-5.46

-87.64%

Exceptional Items

0.00

Gross Profit (PBDT)

3.39

9.48

-6.09

-64.24%

Depreciation

0.22

5.18

-4.96

-95.75%

Profit Before Tax

3.16

4.31

-1.15

-26.68%

Tax

0.17

0.79

-0.62

-78.48%

Provisions and contingencies

0.00

Profit After Tax

3.00

3.52

-0.52

-14.77%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

3.00

3.52

-0.52

-14.77%

Equity Capital

20.05

12.64

7.41

58.62%

Face Value

10.00

5.00

0.00

Reserves

0.00

Earnings per share (EPS)

1.50

1.39

0.11

7.91%

Diluted Earnings per share

1.49

1.39

0.10

7.19%

Operating Profit Margin (Excl OI)

18.20%

5.35%

0.00

12.85%

Gross Profit Margin

14.87%

3.64%

0.00

11.23%

PAT Margin

13.16%

1.35%

0.00

11.81%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 22.80 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -26.09% vs 0.26% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -3.23% vs 6.56% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 3.00 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -13.04% vs -26.60% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -40.59% vs 37.23% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 4.15 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -0.48% vs -23.77% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -25.09% vs 30.66% in Dec 2024

Quarterly - Interest

Interest 0.77 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 83.33% vs -6.67% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 102.63% vs 2.70% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 18.20%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024